Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 52

Results For "NCEs"

2547 News Found

Biotium acquires CAT5 RNA/DNA extraction technology from Cell Data Sciences
Biotech | May 07, 2022

Biotium acquires CAT5 RNA/DNA extraction technology from Cell Data Sciences

RNAstorm and DNAstorm RNA/DNA extraction kits will be sold exclusively through the Biotium website and authorized distributors


DNA Script partners with Premas Life Sciences for same-day enzymatic DNA synthesis
Biotech | May 05, 2022

DNA Script partners with Premas Life Sciences for same-day enzymatic DNA synthesis

This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India


Scipio bioscience announces its revolutionary Asteria single-cell RNA-seq kit
Biotech | May 04, 2022

Scipio bioscience announces its revolutionary Asteria single-cell RNA-seq kit

At an affordable price, a researcher can process fresh samples of 10,000 cells immediately with a stable stopping point within two hours, simplifying sample management at the laboratory and limiting transcriptional changes


Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore
News | May 04, 2022

Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore

The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings


Xcardia announces first-in-human use of its new Xtractor device
Biotech | May 02, 2022

Xcardia announces first-in-human use of its new Xtractor device

The announcement follows FDA 510(k) clearance of device


NORD announces over US $ 100,000 in grant funding available for rare disease research
Biotech | May 02, 2022

NORD announces over US $ 100,000 in grant funding available for rare disease research

Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program


Beta Drugs announces oultook for FY 22-23
News | April 28, 2022

Beta Drugs announces oultook for FY 22-23

The management believes that its strong product pipeline, diversified innovative product portfolio, continued expansion into new geographies and FGMP accreditations will help sustain the growth momentum in the coming few years


Diadem announces publication of peer-reviewed article on Alzheimer’s disease
Biotech | April 28, 2022

Diadem announces publication of peer-reviewed article on Alzheimer’s disease

It includes multiple studies demonstrating that post-translational modifications of conformational variants of p53 are associated with the pathogenesis of Alzheimer's Disease


CanSinoBIO rebrands to reflect commitment to life sciences research
Biotech | April 25, 2022

CanSinoBIO rebrands to reflect commitment to life sciences research

This is the first major brand refresh of CanSinoBIO since its inception in 2009


IOL Chemicals and Pharmaceuticals commences commercial production of paracetamol
News | April 23, 2022

IOL Chemicals and Pharmaceuticals commences commercial production of paracetamol

All the capex is being met through internal accruals only